tradingkey.logo
tradingkey.logo
Buscar

Drugs Made In America Acquisition Corp

DMAA
Añadir a la lista de seguimiento
10.650USD
+0.010+0.09%
Cierre 07/02, 13:00ETCotizaciones retrasadas 15 min
359.09MCap. mercado
73.88P/E TTM

Más Datos de Drugs Made In America Acquisition Corp Compañía

Drugs Made In America Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The Company intends to focus its search for businesses in the pharmaceutical industry. The Company has neither engaged in any operations nor generated any revenues.

Información de Drugs Made In America Acquisition Corp

Símbolo de cotizaciónDMAA
Nombre de la empresaDrugs Made In America Acquisition Corp
Fecha de salida a bolsaJan 28, 2025
Director ejecutivoStockwell (Lynn)
Número de empleados- -
Tipo de seguridadOrdinary Share
Fin del año fiscalJan 28
Dirección1 East Broward Boulevard
CiudadFT LAUDERDALE
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal33301
Teléfono19548703099
Sitio Web
Símbolo de cotizaciónDMAA
Fecha de salida a bolsaJan 28, 2025
Director ejecutivoStockwell (Lynn)

Ejecutivos de Drugs Made In America Acquisition Corp

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Catherine Do
Dr. Catherine Do
Independent Director Nominee
Independent Director Nominee
100.00K
--
Ms. Lynn Stockwell
Ms. Lynn Stockwell
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
--
--
Dr. G. Sridhar Prasad
Dr. G. Sridhar Prasad
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Myron W. Shulgan
Mr. Myron W. Shulgan
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Saleem Elmasri, CPA
Mr. Saleem Elmasri, CPA
Chief Financial Officer, Principal Financial and Accounting Officer
Chief Financial Officer, Principal Financial and Accounting Officer
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Catherine Do
Dr. Catherine Do
Independent Director Nominee
Independent Director Nominee
100.00K
--
Ms. Lynn Stockwell
Ms. Lynn Stockwell
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
--
--
Dr. G. Sridhar Prasad
Dr. G. Sridhar Prasad
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Myron W. Shulgan
Mr. Myron W. Shulgan
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Saleem Elmasri, CPA
Mr. Saleem Elmasri, CPA
Chief Financial Officer, Principal Financial and Accounting Officer
Chief Financial Officer, Principal Financial and Accounting Officer
--
--

Preguntas frecuentes

¿Quiénes son los cinco principales accionistas de Drugs Made In America Acquisition Corp?

Los cinco principales accionistas de Drugs Made In America Acquisition Corp son: Dr. Catherine Do

¿Cuántas instituciones poseen acciones de Drugs Made In America Acquisition Corp (DMAA)?

A fecha de 2026Q1, 54 instituciones poseen acciones de Drugs Made In America Acquisition Corp, con un valor de mercado combinado de aproximadamente 23.26M, lo que representa el 68.99% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -2073301.00.